SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-024989
Filing Date
2018-04-16
Accepted
2018-04-16 16:23:45
Documents
1
Period of Report
2018-04-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9147
  Complete submission text file 0001209191-18-024989.txt   10640
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address C/O OXIGENE, INC., 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Schwieterman William D (Reporting) CIK: 0001403961 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 18756861